Clinical and biochemical aspects of primary and secondary hyperammonemic disorders
- PMID: 23628343
- DOI: 10.1016/j.abb.2013.04.009
Clinical and biochemical aspects of primary and secondary hyperammonemic disorders
Abstract
An increased concentration of ammonia is a non-specific laboratory sign indicating the presence of potentially toxic free ammonia that is not normally removed. This does occur in many different conditions for which hyperammonemia is a surrogate marker. Hyperammonemia can occur due to increased production or impaired detoxification of ammonia and should, if associated with clinical symptoms, be regarded as an emergency. The conditions can be classified into primary or secondary hyperammonemias depending on the underlying pathophysiology. If the urea cycle is directly affected by a defect of any of the involved enzymes or transporters, this results in primary hyperammonemia. If however the function of the urea cycle is inhibited by toxic metabolites or by substrate deficiencies, the situation is described as secondary hyperammonemia. For removal of ammonia, mammals require the action of glutamine synthetase in addition to the urea cycle, in order to ensure lowering of plasma ammonia concentrations to the normal range. Independent of its etiology, hyperammonemia may result in irreversible brain damage if not treated early and thoroughly. Thus, early recognition of a hyperammonemic state and immediate initiation of the specific management are of utmost importance. The main prognostic factors are, irrespective of the underlying cause, the duration of the hyperammonemic coma and the extent of ammonia accumulation. This paper will discuss the biochemical background of primary and secondary hyperammonemia and will give an overview of the various underlying conditions including a brief clinical outline and information on the genetic backgrounds.
Keywords: Glutamine synthetase; Hyperammonemia; Hyperammonemic coma; N-acetylglutamate synthase; Organic acidemias; Urea cycle disorders.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA.J Hepatol. 2011 Aug;55(2):426-34. doi: 10.1016/j.jhep.2010.11.031. Epub 2010 Dec 13. J Hepatol. 2011. PMID: 21147182
-
Ammonia and autophagy: An emerging relationship with implications for disorders with hyperammonemia.J Inherit Metab Dis. 2019 Nov;42(6):1097-1104. doi: 10.1002/jimd.12061. Epub 2019 Feb 19. J Inherit Metab Dis. 2019. PMID: 30671986 Review.
-
Hyperammonemia, bane of the brain.Clin Pediatr (Phila). 2004 Oct;43(8):683-9. doi: 10.1177/000992280404300801. Clin Pediatr (Phila). 2004. PMID: 15494874 Review.
-
Ammonia metabolism and hyperammonemic disorders.Adv Clin Chem. 2014;67:73-150. doi: 10.1016/bs.acc.2014.09.002. Epub 2014 Nov 4. Adv Clin Chem. 2014. PMID: 25735860 Review.
-
Ammonia toxicity under hyponatremic conditions in astrocytes: de novo synthesis of amino acids for the osmoregulatory response.Neurochem Int. 2005 Jul;47(1-2):39-50. doi: 10.1016/j.neuint.2005.04.005. Neurochem Int. 2005. PMID: 15908044
Cited by
-
Hepatic glutamine synthetase augmentation enhances ammonia detoxification.J Inherit Metab Dis. 2019 Nov;42(6):1128-1135. doi: 10.1002/jimd.12070. Epub 2019 Mar 11. J Inherit Metab Dis. 2019. PMID: 30724386 Free PMC article.
-
Hyperammonemia associated with distal renal tubular acidosis or urinary tract infection: a systematic review.Pediatr Nephrol. 2018 Mar;33(3):485-491. doi: 10.1007/s00467-017-3829-7. Epub 2017 Nov 13. Pediatr Nephrol. 2018. PMID: 29134448
-
Elevated Blood Ammonia Level Is a Potential Biological Risk Factor of Behavioral Disorders in Prisoners.Behav Neurol. 2015;2015:797862. doi: 10.1155/2015/797862. Epub 2015 Sep 17. Behav Neurol. 2015. PMID: 26457003 Free PMC article.
-
Commentary to Aby et al: serum ammonia use - unnecessary, frequent and costly.Frontline Gastroenterol. 2022 Mar 8;13(5):456-457. doi: 10.1136/flgastro-2022-102132. eCollection 2022. Frontline Gastroenterol. 2022. PMID: 36051963 Free PMC article. No abstract available.
-
Low hemoglobin levels are associated with upper gastrointestinal bleeding.Biomed Rep. 2016 Sep;5(3):349-352. doi: 10.3892/br.2016.727. Epub 2016 Jul 27. Biomed Rep. 2016. PMID: 27588176 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical